Locations
Daly City, CA, USA · San Francisco, CA, USA · South San Francisco, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2016
Spruce Biosciences is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological and endocrine disorders with significant unmet medical need. The company is developing tildacerfont as a precision treatment for major depressive disorder (MDD) in collaboration with HMNC Brain Health, utilizing its proprietary diagnostic tool, Cortibon, to identify patients most likely to respond to treatment. Tildacerfont also aims to benefit patients with disorders characterized by elevated levels of adrenocorticotropic hormone (ACTH), including polycystic ovary syndrome (PCOS). With a commitment to transforming patient lives, Spruce is positioned to address significant gaps in treatment for these conditions.
Something looks off?